Funded Grants

PI Name PI Organization Title Grant Number Initiative Program Official Sort ascending
Goel, Ajay

Beckman Research Institute/City Of Hope
United States

Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer 2U01CA214254-06 Matthew Young, Ph.D.
Paulson, Thomas G

Fred Hutchinson Cancer Center
United States

The microbiome ecosystem of Barrett's esophagus and progression to cancer 5R21CA259687-02 PAR-20-292 (R21 Clinical Trial Optional) Matthew Young, Ph.D.
Wu, Yun

State University Of New York At Buffalo
United States

Exosomal Thomsen-Friedenreich glycoantigen as a new biomarker for lung cancer screening and early detection 5R21CA267934-02 PAR-20-292 (R21 Clinical Trial Optional) Matthew Young, Ph.D.
Li, Debiao

Cedars-Sinai Medical Center
United States

Predicting Pancreatic Ductal Adenocarcinoma (PDAC) Through Artificial Intelligence Analysis of Pre-Diagnostic CT Images 5R01CA260955-03 Matthew Young, Ph.D.
Goggins, Michael G.

Johns Hopkins University
United States

Using markers to improve pancreatic cancer screening and surveillance: a multi-center study 5U01CA210170-07 Matthew Young, Ph.D.
Carter, Bob S

Massachusetts General Hospital
United States

Standardized Molecular Analyses of Glioma EVs 5R01CA237500-04 Matthew Young, Ph.D.
Goldman, Radoslav

Georgetown University
United States

O-glycoproteins in the progression of liver disease 5R01CA238455-05 Matthew Young, Ph.D.
Majumder, Shounak

Mayo Clinic Rochester
United States

Mayo Clinic Prospective Resource for Biomarker Validation and Early Detection of Pancreatic Cancer 5U01CA210138-07 Matthew Young, Ph.D.
Oskeritzian, Carole A

University Of South Carolina At Columbia
United States

Development of a noninvasive, rapid and affordable method for early detection of colorectal cancer 5R21CA245651-03 Matthew Young, Ph.D.
Goldman, Radoslav

Georgetown University
United States

O-glycoproteins in the progression of liver disease 5R01CA238455-05 Matthew Young, Ph.D.